M&A Deal Summary

Piramal Enterprises Acquires Valeant Pharmaceuticals Caladryl

On November 1, 2013, Piramal Enterprises acquired consumer products company Valeant Pharmaceuticals Caladryl from Bausch Health

Acquisition Highlights
  • This is Piramal Enterprises’ 1st transaction in the Consumer Products sector.
  • This is Piramal Enterprises’ 3rd transaction in India.

M&A Deal Summary

Date 2013-11-01
Target Valeant Pharmaceuticals Caladryl
Sector Consumer Products
Buyer(s) Piramal Enterprises
Sellers(s) Bausch Health
Deal Type Divestiture

Target

Valeant Pharmaceuticals Caladryl

India
Valeant Pharmaceuticals Caladryl is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Piramal Enterprises

Mumbai, India

Category Company
Founded 1947
Sector Healthcare Services
Employees16,035
Revenue 89.2B INR (2025)
DESCRIPTION

Piramal Enterprises is a diversified Indian conglomerate. Piramal Group operates healthcare, drug discovery and research, glass, real estate and financial services. Piramal Enterprises was founded in 1947 and is based in Mumbai, Maharashtra.


DEAL STATS #
Overall 7 of 12
Sector: Consumer Products M&A 1 of 1
Type: Divestiture M&A Deals 3 of 4
Country: India M&A 3 of 5
Year: 2013 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-10 Shriram Finance

Mumbai, India

Shriram Finance is a finance provider for the commercial vehicle industry with a focus on providing credit facilities to small truck owners. Shriram Finance was founded in 1979 and is based in Mumbai, India.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-15 Shriram Capital

Chennai, India

Shriram Capital is the overarching holding company for the Financial Services and Insurance entities of the Shriram Group, created with the primary objective of optimizing the synergies across the Group’s entities. Shriram Capital was founded in 1974 and is based in Chennai, India.

Buy -

Seller(S) 1

SELLER

Bausch Health

Laval, Quebec, Canada

Category Company
Sector Life Science
Employees20,270
Revenue 9.6B USD (2024)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.


DEAL STATS #
Overall 2 of 10
Sector: Consumer Products M&A 1 of 5
Type: Divestiture M&A Deals 2 of 10
Country: India M&A 1 of 1
Year: 2013 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-27 Bausch & Lomb

Rochester, New York, United States

Bausch & Lomb is a manufacturer of ophthalmic products.

Buy $8.7B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-16 Solta Medical

Hayward, California, United States

Solta Medical is a designer, developer, manufacturer and marketer of medical devices for the non-invasive treatment of wrinkles. Solta Medical was formed in 1996 and is based in Hayward, California.

Buy $250M